Press & Media

Governor Abigail Spanberger and Albemarle County celebrated the launch of a new biomanufacturing facility, marking a big step for a company.

A husband-and-wife team turned their lab work into an FDA-approved drug for acute myeloid leukemia.

UVA Engineering professor Bryan Berger is advancing solutions to protect the food supply while immersing students in real-world innovation.

Last summer, Lytos expanded into a research and manufacturing facility in Waynesboro, marking a significant step forward.

Nanochon, a medical device startup now testing technology designed to help regrow damaged cartilage.

A new statewide program is aiming to help get more university startups off the ground, and faster.

With help from UVA’s Licensing & Ventures Group, Roversa Robotics is transforming how kids around the world learn computer science.

The UVA Licensing & Ventures Group has helped researchers be awarded patents for innovations benefiting untold millions.

UVA’s revamped entrepreneurial system and local business support helped make a lifesaving cancer invention possible.

Current and former UVA professors developed technology professional sports teams are using.

Dr. Shrirang Gadrey and his team have invented a device, called ARK, that allows nurses and doctors to make better measurements of a patient’s breathing.

The Federal Drug Administration recently expanded its clearance for the artificial pancreas that professors Marc Breton and Boris Kovatchev created.

Dr. Timothy Showalter was honored Thursday at the Rotunda for being selected the 2023 Edlich-Henderson Innovator of the Year by the University of Virginia.

“I was frustrated by the tools I had," said Dr. Tim Showalter. So he invented his own.

Timothy N. Showalter, MD, has been selected as the 2023 Edlich-Henderson Innovator of the Year by the University of Virginia. The endowed award recognizes University inventors whose work is making a major impact on society. Showalter, a UVA School of Medicine professor and clinician at the UVA Cancer Center, invented a product for women with […]

Also in this roundup: an influential blog lauds UVA professors for impactful education research, a mathematician earns international recognition and several law professors make news.

The University of Virginia is awarding its Innovator of the Year to a doctor who is helping patients going through cervical cancer treatment.

Dr. Timothy N. Showalter has been selected as the 2023 Edlich-Henderson Innovator of the Year by the University of Virginia.

AgroSpheres is working to create crop products that move away from chemical pesticides.

UVA LVG Executive Director discusses upcoming Global Launchpad event in Charlottesville

University of Virginia alumnus Benjamin Holmes has created a cartilage implant that has the potential to help athletes and non-athletes alike.

Marc Breton was honored at a ceremony last Thursday for his contributions to diabetes research.

UVA professor honored for artificial pancreas invention UVA School of Medicine professor Marc Breton has been awarded the university’s 2022 Edlich-Henderson Innovator of the Year for his role ...

A Charlottesville-based company says its technology is helping families affected by the war in Ukraine.

UVA Licensing & Ventures Group Executive Director Richard W. Chylla and Entrepreneur in Residence Andy Krouse visited with U.S. Treasury Secretary Janet Yellen and others at a Virginia business incubator.

The goal of the new research consortium is to accelerate the translation of discoveries into solutions that benefit society.

A professor with the University of Virginia is trying to make fruits, vegetables, and the entire environment a little safer.

Guided by their mission to maximize the economic impact of UVA discoveries and to improve lives, the Licensing & Ventures Group is now managing a second $10 million “seed fund” for the University.

In the UVA Licensing & Ventures Group’s internship program, students learn about the process of taking early-stage technologies from the lab to the marketplace.

Five questions for Richard Chylla, the UVA Licensing & Ventures Group’s new executive director.

Living with Type 1 diabetes (T1D) requires constant management. Due to a deficient pancreas, food and exercise must be manually balanced against blood sugar and regular insulin injections.

/PRNewswire/ -- Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation...

The National Science Foundation has awarded the University of Virginia a $1.2 million expansion of an earlier grant to develop a secure, high-performance

Three UVA professors aim to revolutionize sports medicine and how the world views human muscle by turning MRI data into 3-D reports that can better treat a wide range of muscle conditions.

Interview with Community of Action member UVA Seed Fund describing lessons learned, new opportunities, and advice for other university gap fund and accelerator programs

PositiveLinks creates an intimate relationship between patients and their care-givers that is proven to keep HIV patients in treatment, thereby improving their own health and squelching transmission of the disease.

The CvilleBioHub has been awarded $548,000 from the GO Virginia initiative to lead the growth and expansion of the biotechnology innovation cluster in Central Virginia.

The $3,000 awards recognize top research, plus mentorship, collaboration and public impact. But hurry – nominations are due Dec. 2.

Early lab results show that ZB131 could reduce growth and even kill multiple types of cancer cells, including ovarian, pancreatic, lung and colorectal. The new funding will go toward manufacturing and testing the drug in human clinical trials.